Skip to main content
SpringerLink
Log in

Pathophysiology of HCC

  • Chapter
  • First Online:
Hepatocellular Carcinoma

Part of the book series: SpringerBriefs in Cancer Research ((BRIEFSCANCER))

  • 1044 Accesses

Abstract

Histopathological features that lead to the initiation and progression of HCC are poorly understood. Tissue microenvironment plays a major role in this process. Interaction of a variety of cell types in the tumor stroma with extracellular matrix components lead to the acquisition of an abnormal phenotype that promotes tumor formation. It has also been demonstrated that hypoxia enhances progression, and metastasis of HCC. Activation of epithelial-mesenchymal transition, oxidative stress, and inflammation also play major roles in tumor progression. Furthermore, cells with ‘stem-like’ features, termed cancer stem cells, are also present in the liver during HCC that promote tumor growth.

This is a preview of subscription content, log in via an institution to check access.

Access this chapter

Log in via an institution
Chapter
USD 29.95
Price excludes VAT (USA)
  • Available as PDF
  • Read on any device
  • Instant download
  • Own it forever
eBook
USD 39.99
Price excludes VAT (USA)
  • Available as EPUB and PDF
  • Read on any device
  • Instant download
  • Own it forever
Softcover Book
USD 54.99
Price excludes VAT (USA)
  • Compact, lightweight edition
  • Dispatched in 3 to 5 business days
  • Free shipping worldwide - see info

Tax calculation will be finalised at checkout

Purchases are for personal use only

Institutional subscriptions

References

  • Abel S, De Kock M, van Schalkwyk DJ, Swanevelder S, Kew MC, Gelderblom WC (2009) Altered lipid profile, oxidative status and hepatitis B virus interactions in human hepatocellular carcinoma. Prostaglandins Leukot Essent Fatty Acids 81(5–6):391–399

    PubMed  CAS  Google Scholar 

  • Al-Hajj M, Wicha MS, Benito-Hernandez A, Morrison SJ, Clarke MF (2003) Prospective identification of tumorigenic breast cancer cells. Proc Natl Acad Sci U S A 100(7):3983–3988

    PubMed  CAS  PubMed Central  Google Scholar 

  • Bae MK, Kwon YW, Kim MS, Bae SK, Bae MH, Lee YM, Kim YJ, Kim KW (1998) Identification of genes differentially expressed by hypoxia in hepatocellular carcinoma cells. Biochem Biophys Res Commun 243(1):158–162

    PubMed  CAS  Google Scholar 

  • Bandyopadhyay S, Pai SK, Gross SC, Hirota S, Hosobe S, Miura K, Saito K, Commes T, Hayashi S, Watabe M, Watabe K (2003) The Drg-1 gene suppresses tumor metastasis in prostate cancer. Cancer Res 63(8):1731–1736

    PubMed  CAS  Google Scholar 

  • Bandyopadhyay S, Pai SK, Hirota S, Hosobe S, Takano Y, Saito K, Piquemal D, Commes T, Watabe M, Gross SC, Wang Y, Ran S, Watabe K (2004) Role of the putative tumor metastasis suppressor gene Drg-1 in breast cancer progression. Oncogene 22(33):5675–5681

    Google Scholar 

  • Barajas M, Mazzolini G, Genové G, Bilbao R, Narvaiza I, Schmitz V, Sangro B, Melero I, Qian C, Prieto J (2001) Gene therapy of orthotopic hepatocellular carcinoma in rats using adenovirus coding for interleukin 12. Hepatology 33(1):52–61

    PubMed  CAS  Google Scholar 

  • Benetti A, Berenzi A, Gambarotti M, Garrafa E, Gelati M, Dessy E, Portolani N, Piardi T, Giulini SM, Caruso A, Invernici G, Parati EA, Nicosia R, Alessandri G (2008) Transforming growth factor-β1 and CD105 promote the migration of hepatocellular carcinoma–derived endothelium. Cancer Res 68(20):8626–8634

    PubMed  CAS  Google Scholar 

  • Bergamini C, Sgarra C, Trerotoli P, Lupo L, Azzariti A, Antonaci S, Giannelli G (2007) Laminin-5 stimulates hepatocellular carcinoma growth through a different function of α6β4 and α3β1 integrins. Hepatology 46(6):1801–1809

    PubMed  CAS  Google Scholar 

  • Bochud PY, Bibert S, Kutalik Z, Patin E, Guergnon J, Nalpas B, Goossens N, Kuske L, Müllhaupt B, Gerlach T, Heim MH, Moradpour D, Cerny A, Malinverni R, Regenass S, Dollenmaier G, Hirsch H, Martinetti G, Gorgiewski M, Bourlière M, Poynard T, Theodorou I, Abel L, Pol S, Dufour JF, Negro F (2012) IL28B alleles associated with poor hepatitis C virus (HCV) clearance protect against inflammation and fibrosis in patients infected with non-1 HCV genotypes. Hepatology 55(2):384–394

    PubMed  CAS  Google Scholar 

  • Bortolami M, Venturi C, Giacomelli L, Scalerta R, Bacchetti S, Marino F, Floreani A, Lise M, Naccarato R, Farinati F (2002) Cytokine, infiltrating macrophage and T cell-mediated response to development of primary and secondary human liver cancer. Dig Liver Dis 34(11):794–801

    PubMed  CAS  Google Scholar 

  • Budhu A, Forgues M, Ye QH, Jia HL, He P, Zanetti KA, Kammula US, Chen Y, Qin LX, Tang ZY, Wang XW (2006) Prediction of venous metastases, recurrence and prognosis in hepatocellular carcinoma based on a unique immune response signature of the liver microenvironment. Cancer Cell 10(2):99–111

    PubMed  CAS  Google Scholar 

  • Campbell JS, Hughes SD, Gilbertson DG, Palmer TE, Holdren MS, Haran AC, Odell MM, Bauer RL, Ren HP, Haugen HS, Yeh MM, Fausto N (2005) Platelet-derived growth factor C induces liver fibrosis, steatosis, and hepatocellular carcinoma. Proc Natl Acad Sci U S A 102(9):3389–3394

    PubMed  CAS  PubMed Central  Google Scholar 

  • Chen L, Chan TH, Yuan YF, Hu L, Huang J, Ma S, Wang J, Dong SS, Tang KH, Xie D, Li Y, Guan XY (2010) CHD1L promotes hepatocellular carcinoma progression and metastasis in mice and is associated with these processes in human patients. J Clin Invest 120(4):1178–1191

    PubMed  CAS  PubMed Central  Google Scholar 

  • Chen KJ, Zhou L, Xie HY, Ahmed TE, Feng XW, Zheng SS (2012) Intratumoral regulatory T cells alone or in combination with cytotoxic T cells predict prognosis of hepatocellular carcinoma after resection. Med Oncol 29(3):1817–1826

    PubMed  Google Scholar 

  • Chew V, Chen J, Lee D, Loh E, Lee J, Lim KH, Weber A, Slankamenac K, Poon RT, Yang H, Ooi LL, Toh HC, Heikenwalder M, Ng IO, Nardin A, Abastado JP (2012) Chemokine-driven lymphocyte infiltration: an early intratumoural event determining long-term survival in resectable hepatocellular carcinoma. Gut 61(3):427–438

    PubMed  CAS  PubMed Central  Google Scholar 

  • Chiba T, Kita K, Zheng YW, Yokosuka O, Saisho H, Iwama A, Nakauchi H, Taniguchi H (2006) Side population purified from hepatocellular carcinoma cells harbors cancer stem cell-like properties. Hepatology 44(1):240–251

    PubMed  CAS  Google Scholar 

  • Chuma M, Hige S, Nakanishi M, Ogawa K, Natsuizaka M, Yamamoto Y, Asaka M (2008) 8-Hydroxy-2'-deoxy-guanosine is a risk factor for development of hepatocellular carcinoma in patients with chronic hepatitis C virus infection. J Gastroenterol Hepatol 23(9):1431–1436

    PubMed  Google Scholar 

  • Cogliati B, Aloia TP, Bosch RV, Alves VA, Hernandez-Blazquez FJ, Dagli ML (2010) Identification of hepatic stem/progenitor cells in canine hepatocellular and cholangiocellular carcinoma. Vet Comp Oncol 8(2):112–121

    PubMed  CAS  Google Scholar 

  • Copple BL (2010) Hypoxia stimulates hepatocyte epithelial to mesenchymal transition by hypoxia inducible factor- and transforming growth factor-β-dependent mechanisms. Liver Int 30(5):669–682

    PubMed  CAS  PubMed Central  Google Scholar 

  • Ding W, You H, Dang H, LeBlanc F, Galicia V, Lu SC, Stiles B, Rountree CB (2010) Epithelial-to-mesenchymal transition of murine liver tumor cells promotes invasion. Hepatology 52(3):945–953

    PubMed  CAS  PubMed Central  Google Scholar 

  • Du H, Yang W, Chen L, Shen B, Peng C, Li H, Ann DK, Yen Y, Qiu W (2012) Emerging role of autophagy during ischemia-hypoxia and reperfusion in hepatocellular carcinoma. Int J Oncol 40(6):2049–2057

    PubMed  CAS  Google Scholar 

  • El-Serag HB, Rudolph KL (2007) Hepatocellular carcinoma: epidemiology and molecular carcinogenesis. Gastroenterology 132(7):2557–2576

    PubMed  CAS  Google Scholar 

  • Elsharkawy AM, Mann DA (2007) Nuclear factor-kB and the hepatic inflammation-fibrosis-cancer axis. Hepatology 46(2):590–597

    PubMed  CAS  Google Scholar 

  • Fallot G, Neuveut C, Buendia MA (2012) Diverse roles of hepatitis B virus in liver cancer. Curr Opin Virol 2(4):467–473

    PubMed  CAS  Google Scholar 

  • Farazi PA, DePinho RA (2006) Hepatocellular carcinoma pathogenesis: from genes to environment. Nat Rev Cancer 6(9):674–687

    PubMed  CAS  Google Scholar 

  • Fey GH, Gauldie J (1990) The acute phase response of the liver in inflammation. Prog Liver Dis 9:89–116

    PubMed  CAS  Google Scholar 

  • Friedman SL (2008) Mechanisms of hepatic fibrogenesis. Gastroenterology 134(6):1655–1669

    PubMed  CAS  PubMed Central  Google Scholar 

  • Fu J, Xu D, Liu Z, Shi M, Zhao P, Fu B, Zhang Z, Yang H, Zhang H, Zhou C, Yao J, Jin L, Wang H, Yang Y, Fu YX, Wang FS (2007a) Increased regulatory T cells correlate with CD8 T-cell impairment and poor survival in hepatocellular carcinoma patients. Gastroenterology 132(7):2328–2339

    PubMed  Google Scholar 

  • Fu Y, Fang Z, Liang Y, Zhu X, Prins P, Li Z, Wang L, Sun L, Jin J, Yang Y, Zha X (2007b) Overexpression of integrin beta1 inhibits proliferation of hepatocellular carcinoma cell SMMC-7721 through preventing Skp2-dependent degradation of p27 via PI3K pathway. J Cell Biochem 102(3):704–718

    PubMed  CAS  Google Scholar 

  • Giannelli G, Fransvea E, Bergamini C, Marinosci F, Antonaci S (2003) Laminin-5 chains are expressed differentially in metastatic and nonmetastatic hepatocellular carcinoma. Clin Cancer Res 9(10 Pt 1):3684–3691

    PubMed  CAS  Google Scholar 

  • Giannelli G, Bergamini C, Fransvea E, Sgarra C, Antonaci S (2005) Laminin-5 with transforming growth factor- β1 induces epithelial to mesenchymal transition in hepatocellular carcinoma. Gastroenterology 129(5):1375–1383

    PubMed  CAS  Google Scholar 

  • Goldberg MA, Schneider TJ (1994) Similarities between the oxygen-sensing mechanisms regulating the expression of vascular endothelial growth factor and erythropoietin. J Biol Chem 269:4355–4359

    PubMed  CAS  Google Scholar 

  • Goldberg MA, Glass GA, Cunnigham JM, Bunn HF (1987) The regulated expression of erythropoietin by two human hepatoma cell lines. Proc Natl Acad Sci USA 84:7972–7976

    PubMed  CAS  PubMed Central  Google Scholar 

  • Goldberg MA, Gaut CC, Bunn HF (1991) Erythropoietin mRNA levels are governed by both the rate of gene transcription and posttranscriptional events. Blood 77:271–277

    PubMed  CAS  Google Scholar 

  • Guan RJ, Ford HL, Fu Y, Li Y, Shaw LM, Pardee AB (2000) Drg-1 as a differentiation-related, putative metastatic suppressor gene in human colon cancer. Cancer Res 60:749–755

    PubMed  CAS  Google Scholar 

  • Hamaguchi T, Iizuka N, Tsunedomi R, Hamamoto Y, Miyamoto T, Iida M, Tokuhisa Y, Sakamoto K, Takashima M, Tamesa T, Oka M (2008) Glycolysis module activated by hypoxia-inducible factor 1α is related to the aggressive phenotype of hepatocellular carcinoma. Int J Oncol 33(4):725–731

    PubMed  CAS  Google Scholar 

  • Han YP, Zhou L, Wang J, Xiong S, Garner WL, French SW, Tsukamoto H (2004) Essential role of matrix metalloproteinases in interleukin-1-induced myofibroblastic activation of hepatic stellate cell in collagen. J Biol Chem 279(6):4820–4828

    PubMed  CAS  PubMed Central  Google Scholar 

  • Heppner GH, Miller FR (1998) The cellular basis of tumor progression. Int Rev Cytol 177:1–56

    PubMed  CAS  Google Scholar 

  • Hiroishi K, Eguchi J, Baba T, Shimazaki T, Ishii S, Hiraide A, Sakaki M, Doi H, Uozumi S, Omori R, Matsumura T, Yanagawa T, Ito T, Imawari M (2010) Strong CD8+ T-cell responses against tumor-associated antigens prolong the recurrence-free interval after tumor treatment in patients with hepatocellular carcinoma. J Gastroenterol 45(4):451–458

    PubMed  CAS  Google Scholar 

  • Iglesias BV, Centeno G, Pascuccelli H, Ward F, Peters MG, Filmus J, Puricelli L, de Kier Joffé EB (2008) Expression pattern of glypican-3 (GPC3) during human embryonic and fetal development. Histol Histopathol 23(11):1333–1340

    PubMed  CAS  Google Scholar 

  • Iwatsuki M, Mimori K, Yokobori T, Ishi H, Beppu T, Nakamori S, Baba H, Mori M (2010) Epithelial–mesenchymal transition in cancer development and its clinical significance. Cancer Sci 101(2):293–299

    PubMed  CAS  Google Scholar 

  • Jelkmann W (1992) Erythropoietin: structure, control of production, and function. Physiol Rev 72:449–489

    PubMed  CAS  Google Scholar 

  • Joshita S, Umemura T, Katsuyama Y, Ichikawa Y, Kimura T, Morita S, Kamijo A, Komatsu M, Ichijo T, Matsumoto A, Yoshizawa K, Kamijo N, Ota M, Tanaka E (2012) Association of IL28B gene polymorphism with development of hepatocellular carcinoma in Japanese patients with chronic hepatitis C virus infection. Hum Immunol 73(3):298–300

    PubMed  CAS  Google Scholar 

  • Kamohara Y, Haraguchi N, Mimori K, Tanaka F, Inoue H, Mori M, Kanematsu T (2008) The search for cancer stem cells in hepatocellular carcinoma. Surgery 144(2):119–124

    PubMed  Google Scholar 

  • Kikkawa Y, Sudo R, Kon J, Mizuguchi T, Nomizu M, Hirata K, Mitaka T (2008) Laminin α5 mediates ectopic adhesion of hepatocellular carcinoma through integrins and/or Lutheran/basal cell adhesion molecule. Exp Cell Res 314(14):2579–2590

    PubMed  CAS  Google Scholar 

  • Kim KR, Moon HE, Kim KW (2002) Hypoxia-induced angiogenesis in human hepatocellular carcinoma. J Mol Med 80:703–714

    PubMed  CAS  Google Scholar 

  • Kim J, Hong SJ, Park JY, Park JH, Yu YS, Park SY, Lim EK, Choi KY, Lee EK, Paik SS, Lee KG, Wang HJ, Do IG, Joh JW, Kim DS (2010) Epithelial-mesenchymal transition gene signature to predict clinical outcome of hepatocellular carcinoma. Cancer Sci 101(6):1521–1528

    PubMed  CAS  Google Scholar 

  • Kitaoka S, Shiota G, Kawasaki H (2009) Serum levels of interleukin-10, interleukin-12 and soluble interleukin-2 receptor in chronic liver disease type C. Hepatogastroenterology 50(53):1569–1574

    Google Scholar 

  • Körner C, Riesner K, Krämer B, Eisenhardt M, Glässner A, Wolter F, Berg T, Müller T, Sauerbruch T, Nattermann J, Spengler U, Nischalke HD (2012) TRAIL receptor I (DR4) polymorphisms C626G and A683C are associated with an increased risk for hepatocellular carcinoma (HCC) in HCV-infected patients. BMC Cancer 12:85

    PubMed  PubMed Central  Google Scholar 

  • Krantz SB (1991) Erythropoietin. Blood 77:419–434

    PubMed  CAS  Google Scholar 

  • Lee TK, Poon RT, Yuen AP, Ling MT, Kwok WK, Wang XH, Wong YC, Guan XY, Man K, Chau KL, Fan ST (2006) Twist overexpression correlates with hepatocellular carcinoma metastasis through induction of epithelial-mesenchymal transition. Clin Cancer Res 12(18):5369–5376

    PubMed  CAS  Google Scholar 

  • Lee WC, Wu TJ, Chou HS, Yu MC, Hsu PY, Hsu HY, Wang CC (2012) The impact of CD4+CD25+ T cells in the tumor microenvironment of hepatocellular carcinoma. Surgery 151(2):213–222

    PubMed  Google Scholar 

  • Leonardi GC, Candido S, Cervello M, Nicolosi D, Raiti F, Travali S, Spandidos DA, Libra M (2012) The tumor microenvironment in hepatocellular carcinoma (review). Int J Oncol 40(6):1733–1747

    PubMed  CAS  Google Scholar 

  • Li YW, Qiu SJ, Fan J, Zhou J, Gao Q, Xiao YS, Xu YF (2011) Intratumoral neutrophils: a poor prognostic factor for hepatocellular carcinoma following resection. J Hepatol 54(3):497–505

    PubMed  Google Scholar 

  • Libbrecht L, Roskams T (2002) Hepatic progenitor cells in human liver diseases. Semin Cell Dev Biol 13(6):389–396

    PubMed  Google Scholar 

  • Lin A, Schildknecht A, Nguyen LT, Ohashi PS (2010) Dendritic cells integrate signals from the tumor microenvironment to modulate immunity and tumor growth. Immunol Lett 127(2):77–84

    PubMed  CAS  Google Scholar 

  • Liu L, Zhu XD, Wang WQ, Shen Y, Qin Y, Ren ZG, Sun HC, Tang ZY (2010) Activation of β-catenin by hypoxia in hepatocellular carcinoma contributes to enhanced metastatic potential and poor prognosis. Clin Cancer Res 16(10):2740–2750

    PubMed  CAS  Google Scholar 

  • Ma S, Chan KW, Hu L, Lee TK, Wo JY, Ng IO, Zheng BJ, Guan XY (2007) Identification and characterization of tumorigenic liver cancer stem/progenitor cells. Gastroenterology 132(7):2542–2556

    PubMed  CAS  Google Scholar 

  • Ma S, Lee TK, Zheng BJ, Chan KW, Guan XY (2008a) CD133+ HCC cancer stem cells confer chemoresistance by preferential expression of the Akt/PKB survival pathway. Oncogene 27(12):1749–1758

    PubMed  CAS  Google Scholar 

  • Ma S, Chan KW, Lee TK, Tang KH, Wo JY, Zheng BJ, Guan XY (2008b) Aldehyde dehydrogenase discriminates the CD133 liver cancer stem cell populations. Mol Cancer Res 6(7):1146–1153

    PubMed  CAS  Google Scholar 

  • Maeda S, Kamata H, Luo JL, Leffert H, Karin M (2005) IKKβ couples hepatocyte death to cytokine-driven compensatory proliferation that promotes chemical hepatocarcinogenesis. Cell 121(7):977–990

    PubMed  CAS  Google Scholar 

  • Maegdefrau U, Amann T, Winklmeier A, Braig S, Schubert T, Weiss TS, Schardt K, Warnecke C, Hellerbrand C, Bosserhoff AK (2009) Bone morphogenetic protein 4 is induced in hepatocellular carcinoma by hypoxia and promotes tumour progression. J Pathol 218(4):520–529

    PubMed  CAS  Google Scholar 

  • Mantovani A, Sica A, Allavena P, Garlanda C, Locati M (2009) Tumor-associated macrophages and the related myeloid-derived suppressor cells as a paradigm of the diversity of macrophage activation. Hum Immunol 70(5):325–330

    PubMed  CAS  Google Scholar 

  • Mantovani A, Germano G, Marchesi F, Locatelli M, Biswas SK (2011) Cancer-promoting tumor-associated macrophages: new vistas and open questions. Eur J Immunol 41(9):2522–2525

    PubMed  CAS  Google Scholar 

  • Marabita F, Aghemo A, De Nicola S, Rumi MG, Cheroni C, Scavelli R, Crimi M, Soffredini R, Abrignani S, De Francesco R, Colombo M (2011) Genetic variation in the interleukin-28B gene is not associated with fibrosis progression in patients with chronic hepatitis C and known date of infection. Hepatology 54(4):1127–1134

    PubMed  CAS  Google Scholar 

  • Marra M, Sordelli IM, Lombardi A, Lamberti M, Tarantino L, Giudice A, Stiuso P, Abbruzzese A, Sperlongano R, Accardo M, Agresti M, Caraglia M, Sperlongano P (2011) Molecular targets and oxidative stress biomarkers in hepatocellular carcinoma: an overview. J Transl Med 9:171

    PubMed  CAS  PubMed Central  Google Scholar 

  • Mathai AM, Kapadia MJ, Alexander J, Kernochan LE, Swanson PE, Yeh MM (2012) Role of Foxp3-positive tumor-infiltrating lymphocytes in the histologic features and clinical outcomes of hepatocellular carcinoma. Am J Surg Pathol 36(7):980–986

    PubMed  Google Scholar 

  • Matsuo N, Shiraha H, Fujikawa T, Takaoka N, Ueda N, Tanaka S, Nishina S, Nakanishi Y, Uemura M, Takaki A, Nakamura S, Kobayashi Y, Nouso K, Yagi T, Yamamoto K (2009) Twist expression promotes migration and invasion in hepatocellular carcinoma. BMC Cancer 9:240

    PubMed  PubMed Central  Google Scholar 

  • Merlo LM, Pepper JW, Reid BJ, Maley CC (2006) Cancer as an evolutionary and ecological process. Nat Rev Cancer 6(12):924–935

    PubMed  CAS  Google Scholar 

  • Miner JH (2008) Laminins and their roles in mammals. Microsc Res Tech 71(5):349–356

    PubMed  CAS  Google Scholar 

  • Mizuno H, Ogura M, Saito Y, Sekine W, Sano R, Gotou T, Oku T, Itoh S, Katabami K, Tsuji T (2008) Changes in adhesive and migratory characteristics of hepatocellular carcinoma (HCC) cells induced by expression of α3β1 integrin. Biochim Biophys Acta 1780:564–570

    PubMed  CAS  Google Scholar 

  • Movahedi K, Laoui D, Gysemans C, Baeten M, Stangé G, Van den Bossche J, Mack M, Pipeleers D, In’t Veld P, De Baetselier P, Van Ginderachter JA (2010) Different tumor microenvironments contain functionally distinct subsets of macrophages derived from Ly6C(high) monocytes. Cancer Res 71(14):5728–5739

    Google Scholar 

  • Mueller L, Goumas FA, Affeldt M, Sandtner S, Gehling UM, Brilloff S, Walter J, Karnatz N, Lamszus K, Rogiers X, Broering DC (2007) Stromal fibroblasts in colorectal liver metastases originate from resident fibroblasts and generate an inflammatory microenvironment. Am J Pathol 171(5):1608–1618

    PubMed  CAS  PubMed Central  Google Scholar 

  • Murata K, Suzuki H, Okano H, Oyamada T, Yasuda Y, Sakamoto A (2010) Hypoxia-induced des-γ-carboxy prothrombin production in hepatocellular carcinoma. Int J Oncol 36(1):161–170

    PubMed  CAS  Google Scholar 

  • Nagoev BS, Abidov MT, Ivanova MR (2002) LPO and free-radical oxidation parameters in patients with acute viral hepatitis. Bull Exp Biol Med 134(6):557–558

    PubMed  CAS  Google Scholar 

  • Nakagawa H, Maeda S, Yoshida H, Tateishi R, Masuzaki R, Ohki T, Hayakawa Y, Kinoshita H, Yamakado M, Kato N, Shiina S, Omata M (2009) Serum IL-6 levels and the risk for hepatocarcinogenesis in chronic hepatitis C patients: an analysis based on gender differences. Int J Cancer 125(10):2264–2269

    PubMed  CAS  Google Scholar 

  • Nakazaki H (1992) Preoperative and postoperative cytokines in patients with cancer. Cancer 70(3):709–713

    PubMed  CAS  Google Scholar 

  • Naugler WE, Sakurai T, Kim S, Maeda S, Kim K, Elsharkawy AM, Karin M (2007) Gender disparity in liver cancer due to sex differences in MyD88-dependent IL-6 production. Science 317(5834):121–124

    PubMed  CAS  Google Scholar 

  • Nkabyo YS, Ziegler TR, Gu LH, Watson WH, Jones DP (2002) Glutathione and thioredoxin redox during differentiation in human colon epithelial (Caco-2) cells. Am J Physiol Gastrointest Liver Physiol 283(6):G1352–G1359

    PubMed  CAS  Google Scholar 

  • Niu RF, Zhang L, Xi GM, Wei XY, Yang Y, Shi YR, Hao XS (2007) Up-regulation of twist induces angiogenesis and correlates with metastasis in hepatocellular carcinoma. J Exp Clin Cancer Res 26(3):385–394

    PubMed  CAS  Google Scholar 

  • O’Beirne J, Farzaneh F, Harrison PM (2010) Generation of functional CD8+ T cells by human dendritic cells expressing glypican-3 epitopes. J Exp Clin Cancer Res 29(1):48

    PubMed  PubMed Central  Google Scholar 

  • Okuda M, Li K, Beard MR, Showalter LA, Scholle F, Lemon SM, Weinman SA (2002) Mitochondrial injury, oxidative stress, and antioxidant gene expression are induced by hepatitis C virus core protein. Gastroenterology 122(2):366–375

    PubMed  CAS  Google Scholar 

  • Park EJ, Lee JH, Yu GY, He G, Ali SR, Holzer RG, Osterreicher CH, Takahashi H, Karin M (2007) Dietary and genetic obesity promote liver inflammation and tumorigenesis by enhancing IL-6 and TNF expression. Cell 140(2):197–208

    Google Scholar 

  • Piao LS, Hur W, Kim TK, Hong SW, Kim SW, Choi JE, Sung PS, Song MJ, Lee BC, Hwang D, Yoon SK (2012) CD133+ liver cancer stem cells modulate radioresistance in human hepatocellular carcinoma. Cancer Lett 315(2):129–137

    PubMed  CAS  Google Scholar 

  • Pietras K, Ostman A (2010) Hallmarks of cancer: interactions with the tumor stroma. Exp Cell Res 316(8):1324–1331

    PubMed  CAS  Google Scholar 

  • Ramaiah SK, Rittling S (2008) Pathophysiological role of osteopontin in hepatic inflammation, toxicity, and cancer. Toxicol Sci 103(1):4–13

    PubMed  CAS  Google Scholar 

  • Reya T, Morrison SJ, Clarke MF, Weissman IL (2001) Stem cells, cancer, and cancer stem cells. Nature 414(6859):105–111

    PubMed  CAS  Google Scholar 

  • Roskams T, Kojiro M (2010) Pathology of early hepatocellular carcinoma: conventional and molecular diagnosis. Semin Liver Dis 31(1):17–25

    Google Scholar 

  • Salnikov AV, Groth A, Apel A, Kallifatidis G, Beckermann BM, Khamidjanov A, Ryschich E, Buchler MW, Herr I, Moldenhaur G (2009) Targeting of cancer stem cell marker EpCAM by bispecific antibody EpCAMxCD3 inhibits pancreatic carcinoma. J Cell Mol Med 13(9B):4023–4033

    PubMed  Google Scholar 

  • Schrader J, Iredale JP (2011) The inflammatory microenvironment of HCC – the plot becomes complex. J Hepatol 54(5):853–855

    PubMed  Google Scholar 

  • Semenza GL (2003) Targeting HIF-1 for cancer therapy. Nat Rev Cancer 3:721–732

    PubMed  CAS  Google Scholar 

  • Severi T, van Malenstein H, Verslype C, van Pelt JF (2010) Tumor initiation and progression in hepatocellular carcinoma: risk factors, classification, and therapeutic targets. Acta Pharmacol Sin 31(11):1409–1420

    PubMed  CAS  Google Scholar 

  • Shi GM, Xu Y, Fan J, Zhou J, Yang XR, Qiu SJ, Liao Y, Wu WZ, Ji Y, Ke AW, Ding ZB, He YZ, Wu B, Yang GH, Qin WZ, Zhang W, Zhu J, Min ZH, Wu ZQ (2008) Identification of side population cells in human hepatocellular carcinoma cell lines with stepwise metastatic potentials. J Cancer Res Clin Oncol 134(11):1155–1163

    PubMed  CAS  Google Scholar 

  • Shimoda R, Nagashima M, Sakamoto M, Yamaguchi N, Hirohashi S, Yokota J, Kasai H (1994) Increased formation of oxidative DNA damage, 8-hydroxydeoxyguanosine, in human livers with chronic hepatitis. Cancer Res 54(12):3171–3172

    PubMed  CAS  Google Scholar 

  • Shirakawa H, Suzuki H, Shimomura M, Kojima M, Gotohda N, Takahashi S, Nakagohri T, Konishi M, Kobayashi N, Kinoshita T, Nakatsura T (2009) Glypican-3 expression is correlated with poor prognosis in hepatocellular carcinoma. Cancer Sci 100(8):1403–1407

    PubMed  CAS  Google Scholar 

  • Shweiki D, Itin A, Soffer D, Keshet E (1992) Vascular endothelial growth factor induced by hypoxia may mediate hypoxia-initiated angiogenesis. Nature 359:843–845

    PubMed  CAS  Google Scholar 

  • Sibold S, Roh V, Keogh A, Studer P, Tiffon C, Angst E, Vorburger SA, Weimann R, Candinas D, Stroka D (2007) Hypoxia increases cytoplasmic expression of NDRG1, but is insufficient for its membrane localization in human hepatocellular carcinoma. FEBS Lett 581:989–994

    PubMed  CAS  Google Scholar 

  • Song J, Qu Z, Guo X, Zhao Q, Zhao X, Gao L, Sun K, Shen F, Wu M, Wei L (2009) Hypoxia-induced autophagy contributes to the chemoresistance of hepatocellular carcinoma cells. Autophagy 5(8):1131–1144

    PubMed  CAS  Google Scholar 

  • Suetsugu A, Nagaki M, Aoki H, Motohashi T, Kunisada T, Moriwaki H (2006) Characterization of CD133+ hepatocellular carcinoma cells as cancer stem/progenitor cells. Biochem Biophys Res Commun 351(4):820–824

    PubMed  CAS  Google Scholar 

  • Tanaka H, Yamamoto M, Hashimoto N, Miyakoshi M, Tamakawa S, Yoshie M, Tokusashi Y, Yokoyama K, Yaginuma Y, Ogawa K (2006) Hypoxia-independent overexpression of hypoxia-inducible factor 1α as an early change in mouse hepatocarcinogenesis. Cancer Res 66:11263–11270

    PubMed  CAS  Google Scholar 

  • Tanaka H, Fujita N, Sugimoto R, Urawa N, Horiike S, Kobayashi Y, Iwasa M, Ma N, Kawanishi S, Watanabe S, Kaito M, Takei Y (2008) Hepatic oxidative DNA damage is associated with increased risk for hepatocellular carcinoma in chronic hepatitis C. Br J Cancer 98(3):580–586

    PubMed  CAS  PubMed Central  Google Scholar 

  • Theise ND, Yao JL, Harada K, Hytiroglou P, Portmann B, Thung SN, Tsui W, Ohta H, Nakanuma Y (2003) Hepatic ‘stem cell’ malignancies in adults: four cases. Histopathology 43(3):263–271

    PubMed  CAS  Google Scholar 

  • Thiery JP, Acloque H, Huang RY, Nieto MA (2009) Epithelial-mesenchymal transitions in development and disease. Cell 139(5):871–890

    PubMed  CAS  Google Scholar 

  • Toffoli S, Michiels C (2008) Intermittent hypoxia is a key regulator of cancer cell and endothelial cell interplay in tumours. FEBS J 275:2991–3002

    PubMed  CAS  Google Scholar 

  • Tomuleasa C, Soritau O, Rus-Ciuca D, Pop T, Todea D, Mosteanu O, Pintea B, Foris V, Susman S, Kacsó G, Irimie A (2010) Isolation and characterization of hepatic cancer cells with stem-like properties from hepatocellular carcinoma. J Gastrointesin Liver Dis 19(1):61–67

    Google Scholar 

  • Trinchieri G (2003) Interleukin-12 and the regulation of innate resistance and adaptive immunity. Nat Rev Immunol 3(2):133–146

    PubMed  CAS  Google Scholar 

  • Tsai SM, Lin SK, Lee KT, Hsiao JK, Huang JC, Wu SH, Ma H, Wu SH, Tsai LY (2009) Evaluation of redox statuses in patients with hepatitis B virus-associated hepatocellular carcinoma. Ann Clin Biochem 46(Pt 5):394–400

    PubMed  CAS  Google Scholar 

  • Uenishi T, Kubo S, Yamamoto T, Shuto T, Ogawa M, Tanaka H, Tanaka S, Kaneda K, Hirohashi K (2003) Cytokeratin 19 expression in hepatocellular carcinoma predicts early postoperative recurrence. Cancer Sci 94(10):851–857

    PubMed  CAS  Google Scholar 

  • van Malenstein H, Gevaert O, Libbrecht L, Daemen A, Allemeersch J, Nevens F, Van Cutsem E, Cassiman D, De Moor B, Verslype C, van Pelt J (2010) A seven-gene set associated with chronic hypoxia of prognostic importance in hepatocellular carcinoma. Clin Cancer Res 16(16):4278–4288

    PubMed  Google Scholar 

  • van Zijl F, Mair M, Csiszar A, Schneller D, Zulehner G, Huber H, Eferl R, Beug H, Dolznig H, Mikulits W (2009a) Hepatic tumor-stroma crosstalk guides epithelial to mesenchymal transition at the tumor edge. Oncogene 28(45):4022–4033

    PubMed  PubMed Central  Google Scholar 

  • van Zijl F, Zulehner G, Petz M, Schneller D, Kornauth C, Hau M, Machat G, Grubinger M, Huber H, Mikulits W (2009b) Epithelial-mesenchymal transition in hepatocellular carcinoma. Future Oncol 5(8):1169–1179

    PubMed  Google Scholar 

  • Visvader JE, Lindeman GJ (2008) Cancer stem cells in solid tumours: accumulating evidence and unresolved questions. Nat Rev Cancer 8(10):755–768

    PubMed  CAS  Google Scholar 

  • Wang Y, Kato N, Hoshida Y, Yoshida H, Taniguchi H, Goto T, Moriyama M, Otsuka M, Shiina S, Shiratori Y, Ito Y, Omata M (2003) Interleukin-1β gene polymorphisms associated with hepatocellular carcinoma in hepatitis C virus infection. Hepatology 37(1):65–71

    PubMed  CAS  Google Scholar 

  • Wang F, Jing X, Li G, Wang T, Yang B, Zhu Z, Gao Y, Zhang Q, Yang Y, Wang Y, Wang P, Du Z (2012) Foxp3+ regulatory T cells are associated with the natural history of chronic hepatitis B and poor prognosis of hepatocellular carcinoma. Liver Int 32(4):644–655

    PubMed  CAS  Google Scholar 

  • Wenger RH, Rolfs A, Marti HH, Bauer C, Gassmann M (1995) Hypoxia, a novel inducer of acute phase gene expression in a human hepatoma cell line. J Biol Chem 270:27865–12870

    PubMed  CAS  Google Scholar 

  • Wheelhouse NM, Chan YS, Gillies SE, Caldwell H, Ross JA, Harrison DJ, Prost S (2003) TNF-α induced DNA damage in primary murine hepatocytes. Int J Mol Med 12(6):889–894

    PubMed  CAS  Google Scholar 

  • Wong VW, Yu J, Cheng AS, Wong GL, Chan HY, Chu ES, Ng EK, Chan FK, Sung JJ, Chan HL (2009) High serum interleukin-6 level predicts future hepatocellular carcinoma development in patients with chronic hepatitis B. Int J Cancer 124(12):2766–2770

    PubMed  CAS  Google Scholar 

  • Wu XZ, Xie GR, Chen D (2007) Hypoxia and hepatocellular carcinoma: the therapeutic target for hepatocellular carcinoma. J Gastroenterol Hepatol 22:1178–1182

    PubMed  CAS  Google Scholar 

  • Wu K, Kryczek I, Chen L, Zou W, Welling TH (2009) Kupffer cell suppression of CD8+ T cells in human hepatocellular carcinoma is mediated by B7-H1/programmed death-1 interactions. Cancer Res 69(20):8067–8075

    PubMed  CAS  Google Scholar 

  • Wu SD, Ma YS, Fang Y, Liu LL, Fu D, Shen XZ (2012) Role of the microenvironment in hepatocellular carcinoma development and progression. Cancer Treat Rev 38(3):218–225

    PubMed  CAS  Google Scholar 

  • Xiong YQ, Sun HC, Zhang W, Zhu XD, Zhuang PY, Zhang JB, Wang L, Wu WZ, Qin LX, Tang ZY (2009) Human hepatocellular carcinoma tumor-derived endothelial cells manifest increased angiogenesis capability and drug resistance compared with normal endothelial cells. Clin Cancer Res 15(15):4838–4846

    PubMed  CAS  Google Scholar 

  • Yamashita YI, Shimada M, Hasegawa H, Minagawa R, Rikimaru T, Hamatsu T, Tanaka S, Shirabe K, Miyazaki JI, Sugimachi K (2001) Electroporation-mediated interleukin-12 gene therapy for hepatocellular carcinoma in the mice model. Cancer Res 61(3):1005–1012

    PubMed  CAS  Google Scholar 

  • Yamashita T, Forgues M, Wang W, Kim JW, Ye Q, Jia H, Budhu A, Zanetti KA, Chen Y, Qin LX, Tang ZY, Wang XW (2008) EpCAM and alpha-fetoprotein expression defines novel prognostic subtypes of hepatocellular carcinoma. Cancer Res 68(5):1451–1461

    PubMed  CAS  Google Scholar 

  • Yamashita T, Ji J, Budhu A, Forgues M, Yang W, Wang HY, Jia H, Ye Q, Qin LX, Wauthier E, Reid LM, Minato H, Honda M, Kaneko S, Tang ZY, Wang XW (2009) EpCAM-positive hepatocellular carcinoma cells are tumor-initiating cells with stem/progenitor cell features. Gastroenterology 136(3):1012–1024

    PubMed  CAS  PubMed Central  Google Scholar 

  • Yan W, Fu Y, Tian D, Liao J, Liu M, Wang B, Xia L, Zhu Q, Luo M (2009) PI3 kinase/Akt signaling mediates epithelial-mesenchymal transition in hypoxic hepatocellular carcinoma cells. Biochem Biophys Res Commun 382(3):631–636

    PubMed  CAS  Google Scholar 

  • Yan W, Chang Y, Liang X, Cardinal JS, Huang H, Thorne SH, Monga SP, Geller DA, Lotze MT, Tsung A (2012) High-mobility group box 1 activates caspase-1 and promotes hepatocellular carcinoma invasiveness and metastases. Hepatology 55(6):1863–1875

    PubMed  CAS  Google Scholar 

  • Yang Z, Ho DW, Ng MN, Lau NCK, Yu WC, Ngai P, Chu PWK, Lam CT, Poon RTP, Fan ST (2008) Significance of CD90+ cancer stem cells in human liver cancer. Cancer Cell 13:153–166

    PubMed  CAS  Google Scholar 

  • Yang MH, Chen CL, Chau GY, Chiou SH, Su CW, Chou TY, Peng WL, Wu JC (2009) Comprehensive analysis of the independent effect of twist and snail in promoting metastasis of hepatocellular carcinoma. Hepatology 50(5):1464–1474

    PubMed  CAS  Google Scholar 

  • Yang JD, Nakamura I, Roberts LR (2011) The tumor microenvironment in hepatocellular carcinoma: current status and therapeutic targets. Semin Cancer Biol 21(1):35–43

    PubMed  CAS  PubMed Central  Google Scholar 

  • Yin S, Li J, Hu C, Chen X, Yao M, Yan M, Jiang G, Ge C, Xie H, Wan D, Yang S, Zheng S, Gu J (2007) CD133 positive hepatocellular carcinoma cells possess high capacity for tumorigenicity. Int J Cancer 120(7):1444–1450

    PubMed  CAS  Google Scholar 

  • Yu H, Pardoll D, Jove R (2009) STATs in cancer inflammation and immunity: a leading role for STAT3. Nat Rev Cancer 9(11):798–809

    PubMed  CAS  Google Scholar 

  • Zhang Y, Yang B, Du Z, Bai T, Gao YT, Wang YJ, Lou C, Wang FM, Bai Y (2007) Aberrant methylation of SPARC in human hepatocellular carcinoma and its clinical implication. World J Gastroenterol 18(17):2043–2052

    Google Scholar 

  • Zhu Z, Hao X, Yan M, Yao M, Ge C, Gu J, Li J (2010) Cancer stem/progenitor cells are highly enriched in CD133+CD44+ population in hepatocellular carcinoma. Int J Cancer 126(9):2067–2078

    PubMed  CAS  Google Scholar 

Download references

Author information

Authors and Affiliations

  1. Department of Radiology, University of Minnesota Medical School, Minneapolis, USA

    Rajagopal N. Aravalli

  2. Departments of Medicine and Genetics and Cell Biology and Development, University of Minnesota, Minneapolis, USA

    Clifford J. Steer

Authors
  1. Rajagopal N. Aravalli
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. Clifford J. Steer
    View author publications

    You can also search for this author in PubMed Google Scholar

Rights and permissions

Reprints and permissions

Copyright information

© 2014 The Author(s)

About this chapter

Cite this chapter

Aravalli, R.N., Steer, C.J. (2014). Pathophysiology of HCC. In: Hepatocellular Carcinoma. SpringerBriefs in Cancer Research. Springer, Cham. https://doi.org/10.1007/978-3-319-09414-4_4

Download citation

Publish with us

Policies and ethics

Search

Navigation